BPC-157 For Sale — Research Grade
Body protection compound 157 (BPC-157) is a widely investigated pentadecapeptide in preclinical tissue regeneration and cellular signaling research. PX1 Research provides high-purity, research-grade BPC-157 synthesized in USA-based, GMP-compliant facilities exclusively for laboratory and in vitro experimentation. Every production lot undergoes independent analytical validation, ensuring precise sequence fidelity, minimal endotoxin levels, and uncompromised batch-to-batch consistency.
Quick answer
Body protection compound 157 (BPC-157) is a widely investigated pentadecapeptide in preclinical tissue regeneration and cellular signaling research. PX1 Research provides high-purity, research-grade BPC-157 synthesized in USA-based, GMP-compliant facilities exclusively for laboratory and in vitro experimentation. Every production lot undergoes independent analytical validation, ensuring precise sequence fidelity, minimal endotoxin levels, and uncompromised batch-to-batch consistency.
Key takeaways
- When procuring reagents for controlled laboratory environments, investigators require verified chemical identity and absolute purity.
- [BPC-157](/research-peptides/bpc-157) is a 15-amino acid pentadecapeptide derived from a naturally occurring gastric protein sequence (specifically, human gastric juice protein BPC).
- The primary focus of [BPC-157](/research-peptides/bpc-157) research centers on its role as a tissue repair peptide.
- To contextualize [BPC-157](/research-peptides/bpc-157) within tissue repair and cellular remodeling literature, researchers frequently compare its pathways to other prominent peptide compounds.
Sourcing High-Purity BPC-157 for Laboratory Research
When procuring reagents for controlled laboratory environments, investigators require verified chemical identity and absolute purity. Commercially available synthetic peptides can exhibit significant variability in residual counterions, truncated sequences, and heavy metal contamination if synthesis and purification parameters are not strictly maintained. PX1 Research satisfies these institutional standards by delivering USA-synthesized, HPLC-verified high-purity BPC-157 tailored specifically for rigorous in vitro and animal model protocols.
Our manufacturing process utilizes modern solid-phase peptide synthesis (SPPS) within GMP-compliant facilities, followed by multi-stage preparative high-performance liquid chromatography (HPLC). Each lot is assigned a dedicated Certificate of Analysis (COA) issued by an independent ISO 17025-accredited analytical laboratory. By maintaining rigorous quality control frameworks, PX1 Research ensures that research teams receive stable, unadulterated reference materials designed to yield reproducible scientific data across diverse biochemical assays.
Chemical Structure and Molecular Properties of BPC-157
BPC-157 is a 15-amino acid pentadecapeptide derived from a naturally occurring gastric protein sequence (specifically, human gastric juice protein BPC). Its primary amino acid sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, yielding a molecular formula of C62H98N16O22 and a nominal molecular weight of approximately 1419.5 Da. Unlike many linear signaling peptides that degrade rapidly in biological fluids, BPC-157 exhibits unusual conformational stability in gastric juice models and standard buffer formulations.
Researchers in our preclinical research library frequently study the structural integrity of BPC-157 under varied enzymatic and pH environments. Its intrinsic resistance to enzymatic cleavage is attributed in part to its proline-rich sequence motif, which induces structural constraints that limit recognition by common endopeptidases. This inherent physical stability makes BPC-157 an ideal candidate peptide for evaluating extended signaling cascades in cell culture assays and rodent models.
Preclinical Mechanisms: Angiogenesis and Cellular Migration
The primary focus of BPC-157 research centers on its role as a tissue repair peptide. Preclinical studies suggest that BPC-157 accelerates the repair of tendon, ligament, muscle, and gut lining tissues primarily through the upregulation of pro-angiogenic factors and the enhancement of cellular migration to damaged sites. In vitro assays demonstrate that BPC-157 exposure stimulates vascular endothelial growth factor receptor 2 (VEGFR2) activation and downstream internal signaling pathways, promoting early endothelial cell proliferation and capillary tube formation.
Additionally, rodent injury models demonstrate that BPC-157 administration increases the expression of focal adhesion kinase (FAK) and paxillin. These structural proteins are vital for focal adhesion assembly, enabling tendon fibroblasts, myoblasts, and epithelial cells to migrate rapidly across injured extracellular matrices. In preclinical tendon and ligament transection models, BPC-157 treated tissues demonstrate increased collagen organization, higher tensile strength, and accelerated restoration of structural tissue density compared to untreated control groups.
Comparative Analysis: BPC-157 vs. TB-500, GHK-Cu, and AOD-9604
To contextualize BPC-157 within tissue repair and cellular remodeling literature, researchers frequently compare its pathways to other prominent peptide compounds. While BPC-157 operates largely via local VEGFR2 activation, FAK signaling, and nitric oxide pathway modulation, TB-500 (a synthetic fragment of Thymosin Beta-4) functions primarily through actin sequestration and cellular motility regulation. In contrast, GHK-Cu functions as a copper-binding tripeptide that regulates gene expression associated with extracellular matrix remodeling and collagen synthesis, whereas AOD-9604 targets metabolic pathways and lipolysis without direct tissue-repair signaling.
Selecting the appropriate peptide depends heavily on the biological model under evaluation. For investigators focusing on microvascular recruitment and connective tissue fibroblast migration, BPC-157 offers targeted pro-angiogenic profiles. Conversely, studies investigating systemic cell migration or extracellular matrix gene transcription may integrate TB-500 or GHK-Cu into comparative assay designs to map complementary cellular pathways.
Gastrointestinal and Epithelial Integrity Models
Beyond musculoskeletal research, BPC-157 is extensively evaluated in models of mucosal damage and gastrointestinal barrier breach. In vitro data indicate that BPC-157 helps maintain epithelial tight junction integrity during oxidative stress or chemical disruption. Preclinical models of inflammatory bowel conditions, gastric ulceration, and anastomotic healing frequently utilize BPC-157 to observe its protective effects on mucosal cell layers.
These protective actions appear linked to the peptide's interplay with the early growth response 1 (EGR-1) gene and nitric oxide (NO) synthase expression. By modulating inducible and endothelial NO production, BPC-157 helps balance local vascular tone and tissue perfusion, dampening excessive pro-inflammatory cytokine cascades. Further research within gastrointestinal epithelial research continues to map these precise transcriptional pathways in enterocyte cultures.
Analytical Purity Verification: HPLC, Mass Spectrometry, and Endotoxin Testing
PX1 Research enforces stringent purity thresholds for all research compounds. Every lot of BPC-157 undergoes ultra-performance liquid chromatography (UPLC/HPLC) to confirm chromatogram peak purity exceeding 99.0%. Mass spectrometry (MS) electrospray ionization is performed concurrently to verify molecular mass fidelity, ruling out amino acid deletions, side-chain modifications, or synthesis fragments.
Because biological assays—particularly cell cultures and animal models—are sensitive to bacterial contaminants, PX1 Research subjects all peptide lots to chromogenic Limulus Amebocyte Lysate (LAL) testing. We maintain strict endotoxin limits (<0.01 EU/mg), ensuring that researchers receive ultra-clean materials that will not trigger non-specific immune activations or confound inflammatory cytokine readouts. Full lot-specific documentation is downloadable via our analytical database for verified institutional wholesale accounts.
Solubility, Handling, and Reconstitution Protocols in Vitro
BPC-157 is supplied as a lyophilized (freeze-dried) sterile powder in sealed glass vials. To preserve structural stability, lyophilized vials should be stored at -20°C or -80°C upon receipt, shielded from light exposure. When preparing solutions for laboratory experimentation, investigators should follow standardized reconstituting protocols using sterile, laboratory-grade solvents such as bacteriostatic water, sterile 0.9% normal saline, or phosphate-buffered saline (PBS).
During reconstitution, solvent should be introduced along the inner glass wall of the vial without direct high-pressure impact onto the lyophilized cake. Gently swirl the vial until complete dissolution occurs; vigorous shaking or vortexing must be avoided to prevent mechanical shear stress and peptide denaturation. Reconstituted stock solutions should be aliquoted and stored at 2°C to 8°C for short-term use, or re-frozen at -20°C to avoid repeated freeze-thaw cycles. Comprehensive guidance is available in our laboratory peptide reconstitution protocol.
Logistics, Cold-Chain Maintenance, and Fulfillment
PX1 Research recognizes that experimental timelines depend on reliable reagent availability and fast delivery. We maintain robust inventory levels of BPC-157 across dual dispatch facilities located in California and Arizona. Orders placed before 3:00 PM EST Monday through Friday are processed for same-day shipping, ensuring minimal transit delays.
All products are shipped in protective temperature-controlled packaging engineered to cushion glass vials and shield the peptide from thermal spikes during transit. While lyophilized BPC-157 displays excellent room-temperature stability over short transport periods, fast domestic shipping guarantees that researchers receive compounds in optimal condition for immediate laboratory deployment.
Frequently Asked Questions
What purity level is guaranteed for PX1 Research BPC-157?
PX1 Research guarantees a minimum purity threshold of 99.0% for BPC-157, as confirmed by high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis.
What analytical testing accompanies each lot of BPC-157?
Every production lot undergoes independent ISO 17025 laboratory verification. Each order is backed by a downloadable Certificate of Analysis (COA) detailing HPLC purity profiles, mass spectrometry verification, and quantitative LAL endotoxin testing.
What are the primary molecular targets studied with BPC-157 in preclinical models?
BPC-157 is primarily studied for its role in VEGFR2 phosphorylation, focal adhesion kinase (FAK) and paxillin pathway activation, early growth response 1 (EGR-1) gene expression, and nitric oxide synthase (NOS) modulation.
How does BPC-157 compare to TB-500 in preclinical repair models?
While BPC-157 operates primarily via local pro-angiogenic signaling (VEGFR2) and cellular migration factors in gastrointestinal, tendon, and ligament models, TB-500 (Thymosin Beta-4 fragment) works primarily through actin sequestration and systemic cell migration.
What are the recommended storage conditions for lyophilized BPC-157?
Lyophilized BPC-157 should be stored at -20°C or -80°C for long-term stability. Reconstituted solution aliquots should be kept refrigerated at 2°C to 8°C and protected from light.
What are the endotoxin limits for PX1 Research BPC-157?
PX1 Research enforces strict endotoxin limits below 0.01 EU/mg, verified via LAL assay testing to prevent confounded immunological or cytokine readouts in cell cultures and animal models.
What solvents are suitable for BPC-157 laboratory reconstitution?
BPC-157 is readily soluble in aqueous solutions including laboratory-grade sterile bacteriostatic water, 0.9% sodium chloride (normal saline), or standard phosphate-buffered saline (PBS).
How quickly do orders ship from PX1 Research?
Orders placed Monday through Friday before 3:00 PM EST ship same-day from our fulfillment facilities in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.